$ELV Balance Sheet | Understand Stock

$ELV

$420.05 -$11.28 (2.61%) Live

$ELV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets:
Cash and cash equivalents
Fixed maturity securities (amortized cost of $26,806 and $25,773; allowance for credit losses of $60 and $21)
Equity securities
Premium receivables, net
Self-funded receivables
Self-funded receivables, net
Other receivables
Other current assets
Assets held for sale
Total current assets

Long-term investments:
Fixed maturity securities (amortized cost of $1,272 and $1,116; allowance for credit losses of $$0 and $0)
Other invested assets
Property and equipment, net
Goodwill
Other intangible assets
Other noncurrent assets
Total assets
Liabilities and equity
Liabilities
Current liabilities:
Medical claims payable
Other policyholder liabilities
Unearned income
Accounts payable and accrued expenses
Short-term borrowings
Current portion of long-term debt
Other current liabilities
Liabilities held for sale
Total current liabilities
Long-term debt, less current portion
Reserves for future policy benefits
Deferred tax liabilities, net
Other noncurrent liabilities
Total liabilities
Preferred stock, shares issued (in shares)
Preferred stock, shares authorized (in shares)
Preferred stock, shares outstanding (in shares)
Shareholders’ equity
Preferred stock, without par value, shares authorized 100,000,000; shares issued and outstanding – none
Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding – 216,113,946 and 220,723,898
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity

Comments